We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Earnings up 20%! But this UK small-cap stock may just be getting started

Are we about to see enduring growth from this UK small-cap business with a rising stock price ahead over the long term?

| More on:
Young female business analyst looking at a graph chart while working from home

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

UK stock Renold (LSE: RNO) is backed by a business with a market capitalisation of around £140m. So it’s a small-cap enterprise and not for widows and orphans.

Nevertheless, the international supplier of industrial chains and related power transmission products has done its shareholders proud over the past few years. But director-speak makes me believe there may be more to come.

Should you buy Renold plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

A multi-bagging share price

In the 2020 pandemic sell-off, the share price plunged to around 6p. Today (17 July), it’s near 59p, and the company just crowned that spectacular progress with a bumper set of full-year results.

Although small-cap stocks can be risky, they can sometimes also deliver high rewards for investors.

However, it would have taken a stout heart to buy the stock in the wake of the pandemic when economies were crashing. I first became interested in November 2021 and typed a bullish article with the stock near 30p.

It’s done all right since then, but chief executive Robert Purcell said in today’s report the business is now at an “inflection point”.  The compounding effect of many recent exciting initiatives is “coming to fruition”.

It’s hard to argue with that assessment. In the 12 months to 31 March 2024, adjusted earnings rose 20% year on year. Net debt dropped by more than 16% too, suggesting a strong cash performance backing up the business progress.

To top-off the positive feel to the report, the directors initiated a small dividend for the year of 0.5p per share. That’s the first in around 19 years, and I think that tells us something about the business and the sector — things can be tough for both.

There’s no denying the cyclicality present here. Indeed, a lot of the strong gains enjoyed by shareholders since 2020 have come from the business turning itself around. Even now, a half-decent general economic down-turn could pull the rug from revenues, earnings, cash flows, dividends, and the share price. To flirt with this stock is to flirt with such ongoing risks.

Steady growth ahead?

But Purcell is optimistic about the company’s future. Continuous improvement initiatives are building an “ever-improving” platform to support the directors’ commercial initiatives.

The focus is on targeting and consolidating the “highly fragmented industrial chain market” with an acquisitive growth strategy. There’s a rich pipeline of “appropriately sized and relatively low-risk opportunities”, Purcell reckons.

Meanwhile, the directors expect the current trading year to be less challenging but they are remaining vigilant.

My assumption is this business is on a long-term growth trajectory now. But progress could be slower than we’ve seen recently. City analysts have pencilled in an increase in normalised earnings of about 13% for this year and 8% next.

However, those potential advances are short of the double- and triple-digit percentage gains seen lately.

Nevertheless, when set against those estimates, the forward-looking earnings multiple looks undemanding at around eight. On balance, and despite the risks, I think this stock is worth further research now with a view to considering the stock for a long-term investment.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »